All Biomarkers

    Factor V Leiden

    Genetic
    Coagulation
    genotype

    Factor V Leiden is an inherited clotting-factor variant that increases the tendency to form venous blood clots. A preventive practice tests it once because carriers face higher risk of deep vein thrombosis and pulmonary embolism, particularly around estrogen use, surgery, or prolonged immobility.

    What It Measures

    Variant predisposing to venous thromboembolism.

    Optimal vs. Lab Range

    Longevity Optimal
    Negative

    Target range for optimal health and longevity based on research.

    Standard Lab
    Negative / Heterozygous / Homozygous

    Population-based reference range from standard labs.

    Why It Matters

    Increases DVT/PE risk, especially with estrogen, surgery, immobility.

    When Low

    When Optimal

    Negative → baseline risk.

    When High

    Heterozygous → 5x VTE risk; manage triggers.

    How to Optimize

    Avoid estrogen contraception if carrier; perioperative DVT prophylaxis.

    Key Interventions & Linked Compounds

    Strong (9/10)

    Key Interventions

    Avoid estrogens (if heterozygous)
    prophylactic anticoagulation around surgery.

    Curated from clinical literature. Individual results vary; consult a qualified clinician before changing a protocol.

    Ordering Notes

    Specimen

    Buccal swab or whole blood (EDTA)

    Patient prep

    No fasting required. Maintain usual diet and medications unless advised.

    Recommended cadence

    Re-test every 3–6 months when actively optimizing; annually for monitoring.

    Reporting unit

    genotype

    Pre-analytic notes

    Standardize draw time of day, hydration, and recent exercise. Note any acute illness, supplements, or hormonal therapies on the requisition.

    Recommended Follow-Up Actions

    1. 1

      Confirm the result is reliable

      Repeat abnormal values before acting — preferably from the same lab, same time of day, and under consistent prep. Rule out acute illness, recent intense exercise, or medication effects that can shift Factor V Leiden.

    2. 2

      Compare against optimal, not just lab range

      Use the optimal window above as the target. Lab "normal" is built from the general population and often misses early dysfunction.

    3. 3

      Pair with related markers

      Order a complementary panel covering metabolic, inflammatory, and hormonal context to interpret this marker properly.

    4. 4

      Discuss interventions with a clinician

      Use the interpretation guidance above to frame the conversation. Bring trends, not just one datapoint, to your visit.

    5. 5

      Re-test on a defined cadence

      If a change is implemented, re-measure in 8–12 weeks for fast-moving markers, or 3–6 months for slower ones, to confirm response before escalating.

    PHS
    671
    / 1000
    T3
    Longevity Operator

    Sample member

    Longevity Operator

    The Peak Human Score · PHS v1

    One number for your longevity journey.

    FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.

    • Metabolic
    • Hormonal
    • Cardiovascular
    • Brain / Cognitive
    • Sleep
    • Musculoskeletal
    • Gut
    • Immunity / Inflammation